The National Cancer Institute (NCI) is developing the cancer Human Biobank (caHUB) through a phased implementation over the next few years (see timeline). The ultimate goal is to establish caHUB as a robust public-private partnership between NCI, other government agencies, academic biomedical research institutions, cancer centers, and industry participants.
During the initial planning phase, caHUB operational/business unit planning subgroups at NCI are developing goals, objectives, and deliverables.
caHUB Planning Subgroups
- Acquisition of Normal Tissues
- Communication and Marketing
- Ethical, Legal, and Social Issues
- Informatics and Data Management
- Strategic Planning and Organizational Structures
Once the subgroups’ action plans are completed, work will start in Phase 1 on the structure for caHUB, including development of the more mature functions of this national resource.
During Phase 2, NCI envisions the implementation of the caHUB private-public partnership, which will:
- Build public trust
- Share risks between the public (government) and private sectors
- Provide greater operating flexibility
- Generate commercial uses that will translate discoveries to the marketplace as drugs or diagnostics for cancer
The Cancer Human Biobank (caHUB)
- You and caHUB
- caHUB Development
- Frequently Asked Questions
- Glossary of Terms